Luisa Salter-Cid joins long­time Bris­tol My­ers col­lab­o­ra­tor Paul Bion­di at Flag­ship's new drug brew­ery

Paul Bion­di is gain­ing a fa­mil­iar re­search chief at his cor­ner of Flag­ship Pi­o­neer­ing.

The am­bi­tious VC — fa­mous for bold plat­form plays such as Mod­er­na — said Luisa Salter-Cid is join­ing Pi­o­neer­ing Med­i­cines as CSO, with the man­date of lever­ag­ing the plat­forms of var­i­ous Flag­ship port­fo­lio com­pa­nies to con­ceive new treat­ments.

The two had crossed paths at Bris­tol My­ers Squibb, where Bion­di brought in a se­ries of new drugs through­out his pro­lif­ic busi­ness de­vel­op­ment stretch while Salter-Cid worked her way up the lad­der to be­come head of im­munol­o­gy, small mol­e­cule im­muno-on­col­o­gy and ge­nomics dis­cov­ery.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN